SYNERDRUG

USPTO USPTO 2001 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke SYNERDRUG wurde als Wortmarke am 03.10.2001 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails Letztes Update: 19. Mai 2018

Markenform Wortmarke
Aktenzeichen 76320908
Anmeldedatum 03. Oktober 2001
Veröffentlichungsdatum 05. März 2002

Markeninhaber

7 Clarke Drive
08512 Cranbury
US

Markenvertreter

Waren und Dienstleistungen

5 describing pharmaceutical preparations that act synergistically with other drugs, for administration via respiratory airways, including small molecules and nucleotide sequences for medical use (or Respiratory Anti-sense OligoNucleotides (RASON)), including aerosolized oligonucleotide preparations for the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, particularly testing, preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating Supra Ventricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemia, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, e.g. cancers which metastasized to the lung(s), breast, liver and prostate included
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376320908